August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden, Bipartisan Senators Applaud Passage of Bipartisan Resolution to End Trump’s Global Tariffs, Call on House to Take Up Final Passage
- Wyden, Paul, Schumer, Kaine Announce Vote on Bipartisan Effort to Repeal Trump’s Global Tariffs, Restore Congressional Authority Over Trade
- Wyden Urges Passage of Bipartisan Legislation to Undo Trump's Canada Tariffs
- Wyden Slams Trump Slapping Blanket Tariffs on Essential Items from Brazil
- Wyden, Schumer, Warren Press Trump Administration on Fake IRS “CEO” Role, Warn That Bisignano Appointment Will Hurt Both IRS and Social Security